Local analgesia during flexible cystoscopy in male patients: A non-inferiority study comparing Xylocaine® gel to Instillagel® Lido

被引:0
|
作者
Peyronnet, B. [1 ]
Drouin, S. -J. [2 ]
Gomez, F. -D. [3 ]
Seisen, T. [2 ]
Goujon, A. [1 ]
Pradere, B. [1 ]
Bitker, M. -O. [2 ]
Phe, V. [2 ]
Roupret, M. [2 ]
机构
[1] CHU Rennes, Urol Serv, F-35000 Rennes, France
[2] Hop La Pitie Salpetriere, AP HP, Urol Serv, 47-83 Blvd Hop, F-75013 Paris, France
[3] CHU Liege, Urol Serv, B-4000 Liege, Belgium
来源
PROGRES EN UROLOGIE | 2016年 / 26卷 / 11-12期
关键词
Cystoscopy; Anesthesia; Gel; Male; Urethra; URETHRAL CATHETERIZATION; LIGNOCAINE GEL; PAIN; LUBRICANT; CHLORHEXIDINE; ANESTHETICS;
D O I
10.1016/j.purol.2016.09.049
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction. - Local anesthesia using urethral gel has been proven to reduce discomfort of male patients during flexible cystoscopy. This study was a non-inferiority study between two lidocain-containing urethral gel (Instillagel (R) Lido and Xylocaine (R) gel). Methods. - A prospective single center study was conducted between June 2014 and November 2014. Male patients seen in the office and in whom a flexible cystoscopy was planned were included in the present study and received urethral instillation of either Xylocaine (R) gel or Instillagel (R) Lido at least 5 minutes before flexible cystoscopy. No other anesthetic agent was used. Primary endpoint was pain during the procedure, assessed through visual analog scale (VAS) from 0 to 10. Results. - Four hundred and sixty-one men were included: 233 in the Instillagel (R) Lido group and 228 in the Xylocaine (R) gel group. Indications of flexible cystoscopy non-muscle invasive bladder cancer follow-up in 44 % of cases, hematuria work-up in 21 % of cases and lower urinary tract symptoms work-up in 35 %. Patients' age was comparable betwwen both groups: 64.5 years (+/- 1.1) in the Instillagel (R) Lido group and 66.2 years (+/- 1.1) in the Xylocaine (R) gel group (P=0.29). The mean VAS was 0.8 (+/- 0.1) in the Instillagel (R) Lido group and 0.6 (+/- 0.1) in the Xylocaine (R) gel group (P=0.10). The non-inferiority criterion was reached (P<0.001) as the average difference in VAS between the two groups was 0.2 with a confidence interval not comprising 1 (Cl 97.5 %: -0.47; 0.07). Conclusion. - In this prospective study, Instillagel (R) Lido was not inferior to Xylocaine (R) gel for local analgesia during flexible cystoscopy in male patients. (C) 2016 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:651 / 655
页数:5
相关论文
共 50 条
  • [31] Safety and feasibility of ureteral stent placement under local anaesthesia using flexible cystoscopy among Male Patients in Hospital Canselor Tuanku Muhriz UKM, Kuala Lumpur: a pilot study
    Yunus, Azrul Aminur Rashid
    Inn, Xeng Fam
    Yi, Li Lim
    Chun, Hau Khoo
    Shukor, Suzliza
    BJU INTERNATIONAL, 2023, 132 (SUPP2) : 7 - 7
  • [32] The Effect of Ultrasound-Guided Erector Spinae Plane Block versus Thoracic Epidural Block on Postoperative Analgesia After Nuss Surgery in Paediatric Patients: Study Protocol of a Randomized Non-Inferiority Design Trial
    Ren, Yi
    Zheng, Tiehua
    Hua, Lei
    Zhang, Fuzhou
    Ma, Yangwei
    Zhang, Jianmin
    JOURNAL OF PAIN RESEARCH, 2021, 14 : 3047 - 3055
  • [33] Encore - a Randomized, Controlled, Open-Label Non-Inferiority Study Comparing Eliglustat to Imiglucerase in Gaucher Disease Type 1 Patients Stabilized on Enzyme Replacement Therapy: 24-Month Results
    Rosenbloom, Barry E.
    Cox, Timothy M.
    Drelichman, Guillermo I.
    Cravo, Renata
    Balwani, Manisha
    Burrow, Thomas Andrew
    Martins, Ana Maria
    Lukina, Elena
    Ross, Leorah H.
    Angell, Jennifer
    Peterschmitt, Judith
    BLOOD, 2014, 124 (21)
  • [34] ENCORE, a randomized, controlled, open-label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients stabilized on enzyme replacement therapy: 24-month results
    Cox, Timothy M.
    Drelichman, Guillermo I.
    Cravo, Renata
    Balwani, Manisha
    Burrow, Thomas Andrew
    Martins, Ana Maria
    Lukinag, Elena
    Rosenbloom, Barry E.
    Ross, Leorah H.
    Angell, Jennifer
    Peterschmitt, M. Judith
    MOLECULAR GENETICS AND METABOLISM, 2015, 114 (02) : S33 - S34
  • [35] Protocol for the RETHINK study: a randomised, double-blind, parallel-group, non-inferiority clinical trial comparing acetaminophen and NSAIDs for treatment of chronic pain in elderly patients with osteoarthritis of the hip and knee
    Endo, Makoto
    Kawahara, Shinya
    Sato, Taishi
    Tokunaga, Masami
    Hara, Toshihiko
    Mawatari, Taro
    Kawano, Tsutomu
    Zenda, Sadamoto
    Miyaji, Tempei
    Shimokawa, Mototsugu
    Sakamoto, Sanae
    Takano, Toshio
    Miyake, Masumi
    Aono, Hiroyuki
    Nakashima, Yasuharu
    RETHINK Study Grp
    BMJ OPEN, 2023, 13 (02):
  • [36] Encore: A Randomized, Controlled, Open-Label Non-Inferiority Study Comparing Eliglustat To Imiglucerase In Gaucher Disease Type 1 Patients On Enzyme Replacement Therapy Who Have Reached Therapeutic Goals
    Burrow, Thomas Andrew
    Balwani, Manisha
    Cox, Timothy M.
    Drelichman, Guillermo
    Cravo, Renata
    Martins, Ana Maria
    Lukina, Elena
    Rosenbloom, Barry E.
    Ross, Leorah H.
    Angell, Jennifer
    Puga, Ana Cristina
    BLOOD, 2013, 122 (21)
  • [37] ENCORE: A randomized, controlled, open-label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients on enzyme replacement therapy who have reached therapeutic goals
    Cox, Timothy M.
    Drelichman, Guillermo
    Cravo, Renata
    Balwani, Manisha
    Burrow, Thomas Andrew
    Martins, Ana Maria
    Lukina, Elena
    Rosenbloom, Barry
    Ross, Leorah
    Angell, Jennifer
    Puga, Ana Cristina
    MOLECULAR GENETICS AND METABOLISM, 2014, 111 (02) : S33 - S33
  • [38] A randomized, open-label, non-inferiority study comparing the efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B-cell non-Hodgkin lymphomas (B-NHL): AVOID neutropenia
    Link, H.
    Illerhaus, G.
    Martens, U. M.
    Salar, A.
    Depenbusch, R.
    Kohler, A.
    Engelhardt, M. M.
    Mahlmann, S.
    Zaiss, M.
    Lammerich, A.
    Bias, P.
    Buchner, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [39] A novel GnRH antagonist protocol based on LH levels versus traditional flexible GnRH antagonist protocol in PCOS patients undergoing in vitro fertilization: study protocol for a randomized controlled, non-inferiority trial
    Liu, Shan
    Lv, Ya-Su
    Han, Shuo
    Liu, Minghui
    Ma, Shuai
    Ren, Haiying
    Li, Yuan
    TRIALS, 2022, 23 (01)
  • [40] A novel GnRH antagonist protocol based on LH levels versus traditional flexible GnRH antagonist protocol in PCOS patients undergoing in vitro fertilization: study protocol for a randomized controlled, non-inferiority trial
    Shan Liu
    Ya-su Lv
    Shuo Han
    Minghui Liu
    Shuai Ma
    Haiying Ren
    Yuan Li
    Trials, 23